Publication scheme

NHS Kernow has followed Information Commissioner guidance and adopted its publication scheme for healthcare.
The publication scheme aims to provide you with information on:

Most of this information will be available on our website. However, some information will only be available in hard copy.

You can also check if the information is in our disclosure log. Our disclosure log contains responses to all the freedom of information requests we have received.

Rebate scheme

Prescribing rebates

NHS Kernow has a policy to agree and consider future prescribing rebates. The arrangements for the drugs are listed below.

Attention deficit hyperactivity disorder: Xaggitin

Company: Ethypharm
Product: Xaggitin
Type: Used to treat attention deficit hyperactivity disorder (ADHD)
Start date: 1 August 2017
End date: Rolling
Aligned to PrescQIPP: Yes

Anti-coagulant: Edoxaban

Company: Daiichi Sankyo
Product: Edoxaban
Type: Anti-coagulant
Start date: 1 April 2018
End date: 31 December 2022
Aligned to PrescQIPP: Yes

Anti-psychotic medicine: Zaluron XL (Quetiapine XL)

Company: Fontus Health Limited
Product: Zaluron XL (Quetiapine XL)
Type: Anti-psychotic medicine
Start date: 1 August 2019
End date: 30 July 2024
Aligned to PrescQIPP: Yes

Atypical anti-psychotic medicine: Quetiapine Biquelle

Company: Aspire Pharma Limited
Product: Quetiapine Biquelle
Type: Atypical anti-psychotic medicine
Start date: 1 April 2021
End date: 31 March 2022
Aligned to PrescQIPP: Yes

Deep vein thrombosis: Rivaroxaban

Company: Bayer
Product: Rivaroxaban
Type: Prevent or treat a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs
Start date: 1 July 2020
End date: 31 March 2024
Aligned to PrescQIPP: Yes

Emollient for eczema: Balneum

Company: Almirall Limited
Product: Balneum
Type: Emollient for eczema
Start date: 23 June 2020
End date: 22 June 2022
Aligned to PrescQIPP: Yes

Inhaler: Clenil Modulite

Company: Chiesi Limited
Product: Clenil Modulite
Type: Inhaler
Start date: 1 August 2021
End date: 31 July 2023
Aligned to PrescQIPP: Yes

Inhaler: Fostair NEXThaler

Company: Chiesi Limited
Product: Fostair NEXThaler
Type: Inhaler
Start date: 1 May 2021
End date: 30 April 2023
Aligned to PrescQIPP: Yes

Inhaler: Fostair pMDI

Company: Chiesi Limited
Product: Fostair pMDI
Type: Inhaler
Start date: 1 August 2021
End date: 31 July 2023
Aligned to PrescQIPP: Yes

Inhaler: Sereflo

Company: CIPLA
Product: Sereflo
Type: Inhaler
Start date: 1 August 2021
End date: 31 July 2023
Aligned to PrescQIPP: Yes

Insulin: Aprida

Company: Aventis Pharma Limited trading as Sanofi
Product: Aprida
Type: Insulin
Start date: 1 April 2021
End date: 31 March 2022
Aligned to PrescQIPP: Yes

Insulin: Insuman

Company: Aventis Pharma Limited trading as Sanofi
Product: Insuman
Type: Insulin
Start date: 1 April 2021
End date: 31 March 2022
Aligned to PrescQIPP: Yes

Insulin: Lispro

Company: Aventis Pharma Limited trading as Sanofi
Product: Lispro
Type: Insulin
Start date: 1 April 2020
End date: 30 September 2021
Aligned to PrescQIPP: Yes

Pain relief patch: Fencino

Company: DS Ashbourne Limited (Part of the Ethypharm Group)
Product: Fencino
Type: Pain relief patch
Start date: 1 April 2016
End date: Rolling
Aligned to PrescQIPP: Yes

Parkinson’s: Pipexus

Company: Ethypharm
Product: Pipexus
Type: For use in the treatment of Parkinson’s
Start date: 1 July 2018
End date: Rolling
Aligned to PrescQIPP: Yes

Prostate cancer: Firmagon® (degarelix)

Company: Ferring Pharmaceuticals
Product: Firmagon® (degarelix)
Type: Treatment for prostate cancer
Start date: 1 September 2019
End date: 31 December 2021
Aligned to PrescQIPP: Yes

Google Translate

Text Size

Change font

Contrast